These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Quality of biotechnological products: analysis of the expression construct in cell lines used for production of r-DNA derived protein products. ICH Harmonised Tripartite Guideline. Dev Biol Stand; 1998; 93():205-8. PubMed ID: 9737397 [No Abstract] [Full Text] [Related]
26. Breast cancer cell lines: friend or foe? Burdall SE; Hanby AM; Lansdown MR; Speirs V Breast Cancer Res; 2003; 5(2):89-95. PubMed ID: 12631387 [TBL] [Abstract][Full Text] [Related]
28. Good Caco-2 cell culture practices. Natoli M; Leoni BD; D'Agnano I; Zucco F; Felsani A Toxicol In Vitro; 2012 Dec; 26(8):1243-6. PubMed ID: 22465559 [TBL] [Abstract][Full Text] [Related]
29. European Union revamps toxicology testing in attempt to limit animal use, improve prediction. Sinha G J Natl Cancer Inst; 2006 Jun; 98(11):728-9. PubMed ID: 16757693 [No Abstract] [Full Text] [Related]
30. [Good cell culture practice--implementation of a relational cell culture database]. Philipp MO; Falkner E; Kapeller B; Eberl H; Frick W; Macfelda K; Losert UM ALTEX; 2002; 19(1):21-6. PubMed ID: 11927979 [TBL] [Abstract][Full Text] [Related]
31. Using Chromatin Immunoprecipitation in Toxicology: A Step-by-Step Guide to Increasing Efficiency, Reducing Variability, and Expanding Applications. McCullough SD; On DM; Bowers EC Curr Protoc Toxicol; 2017 May; 72():3.14.1-3.14.28. PubMed ID: 28463415 [TBL] [Abstract][Full Text] [Related]
32. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations. Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460 [TBL] [Abstract][Full Text] [Related]
33. Evidence-based toxicology - the toolbox of validation for the 21st century? Hartung T ALTEX; 2010; 27(4):253-63. PubMed ID: 21240468 [TBL] [Abstract][Full Text] [Related]
34. Check your cultures! A list of cross-contaminated or misidentified cell lines. Capes-Davis A; Theodosopoulos G; Atkin I; Drexler HG; Kohara A; MacLeod RA; Masters JR; Nakamura Y; Reid YA; Reddel RR; Freshney RI Int J Cancer; 2010 Jul; 127(1):1-8. PubMed ID: 20143388 [TBL] [Abstract][Full Text] [Related]
35. Reproducibility: changing the policies and culture of cell line authentication. Freedman LP; Gibson MC; Ethier SP; Soule HR; Neve RM; Reid YA Nat Methods; 2015 Jun; 12(6):493-7. PubMed ID: 26020501 [No Abstract] [Full Text] [Related]
36. Comprehensive summary--Predict-IV: A systems toxicology approach to improve pharmaceutical drug safety testing. Mueller SO; Dekant W; Jennings P; Testai E; Bois F Toxicol In Vitro; 2015 Dec; 30(1 Pt A):4-6. PubMed ID: 25450741 [TBL] [Abstract][Full Text] [Related]
38. Mutagenesis assays in mammalian cells. Klein CB; Broday L; Costa M Curr Protoc Toxicol; 2001 May; Chapter 3():Unit3.3. PubMed ID: 20941701 [TBL] [Abstract][Full Text] [Related]
39. A silver lining in cell line authentication: Short tandem repeat analysis of 1373 cases in China from 2010 to 2019. Gu M; Yang M; He J; Xia S; Zhang Z; Wang Y; Zheng C; Shen C Int J Cancer; 2022 Feb; 150(3):502-508. PubMed ID: 34469590 [TBL] [Abstract][Full Text] [Related]
40. Quality control in toxicological analysis. Ferrara DS; Tedeschi L; Frison G; Brusini G J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):227-43. PubMed ID: 9700561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]